Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience.

Fabio MinutoliDavide CardileRiccardo LaudicellaAntonio VentoBenedetta PaganoSergio Baldari

Published in: Nuclear medicine and molecular imaging (2021)

Our data furtherly support peptide receptor radionuclide therapy as a safe and effective treatment of patients affected by pulmonary neuroendocrine neoplasms allowing disease control in about 71% of patients without showing significant toxicity. Other studies are needed to confirm our results.

Keyphrases

end stage renal disease
pulmonary hypertension
ejection fraction
chronic kidney disease
peritoneal dialysis
oxidative stress
electronic health record
big data
binding protein
machine learning
cell therapy
patient reported
data analysis
oxide nanoparticles